Skip to main content Skip to footer
Oncidium Foundation
  • Contact us
  • 
  • 
  • 
  • 
  • 
  • About
    • The Oncidium foundation
    • Our ambassadors
    • Our team
    • Supported projects
    • Our sponsors & partners
    • FAQ
    • Contact us
  • Patient support
    • Cancer Types
    • Clinical Trials
    • Stories of hope
  • Access treatment
    • Find a treatment center
    • Register your hospital
  • Radiotheranostics Resources
  • Media
    • Tackle Cancer Challenge
    • News & Events
    • Newsletters
    • Videos
    • Links
  • RLT-connect
  • Donate
  • About
    • The Oncidium foundation
    • Our ambassadors
    • Our team
    • Supported projects
    • Our sponsors & partners
    • FAQ
    • Contact us
  • Patient support
    • Cancer Types
    • Clinical Trials
    • Stories of hope
  • Access treatment
    • Find a treatment center
    • Register your hospital
  • Radiotheranostics Resources
  • Media
    • Tackle Cancer Challenge
    • News & Events
    • Newsletters
    • Videos
    • Links
  • RLT-connect
  • Donate

Radiotherapeutics

Ac-225-RYZ801

Target/Mechanism
GPC3
Carrier/Ligand
Small molecule
Radiation Type
alpha (α)
Back
Corporate Sponsors
Institutions & Programs Partners
RLT-Connect Partners
  • About
  • Patient support
  • Access treatment
  • Our ambassadors
  • Radiotheranostics Resources
  • Media
  • RLT-connect
  • Donate
  • Contact
  • 
  • 
  • 
  • 
  • 

© 2026 | Oncidium Foundation

  • Disclaimer
  • Privacy policy
  • Manage cookies
Newsletter
Journée de Sensibilisation à la RadiotheranostiqueRead more
Nairobi Radiotheranostics Summit 2026Read more
World Radiotheranostics DayRead more
